Davis's Drug Guide
atrasentan
General
Pronunciation:
a-tra-sen-tan
Trade Name(s)
- Vanrafia
Ther. Class.
none assigned
Pharm. Class.
endothelin receptor antagonists
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Atrasentan." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580154/all/atrasentan.
Vallerand AHA, Sanoski CAC. Atrasentan. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580154/all/atrasentan. Accessed August 4, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Atrasentan. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580154/all/atrasentan
Vallerand AHA, Sanoski CAC. Atrasentan [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 04]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580154/all/atrasentan.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - atrasentan
ID - 3580154
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/3580154/all/atrasentan
PB - F.A. Davis Company
ET - 20
DB - The Washington Manual
DP - Unbound Medicine
ER -
